Financials
- Market Capitalization 1.89 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-48.89
Rapporto prezzo/fatturato
4.37
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2012 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.32 USD | -2.80% | +0.21% | +13.03% | -23.21% | 1.99 B USD | ||
| 2028 | XNCR Xencor, Inc. - Common Stock | 26.06 USD | -9.76% | -6.26% | +31.62% | +220.15% | 1.94 B USD | ||
| 2048 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.77 USD | -3.19% | -4.15% | +2.85% | +98.97% | 1.88 B USD | ||
| 2064 | VIR Vir Biotechnology, Inc. - Common Stock | 10.83 USD | -4.24% | +11.19% | +25.78% | +81.10% | 1.83 B USD |